(-)-Epicatechin gallate
Internal ID | 5ca1168a-a7b2-459d-8cb5-fb704bf9981d |
Taxonomy | Phenylpropanoids and polyketides > Flavonoids > Flavans > Catechins > Catechin gallates |
IUPAC Name | [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate |
SMILES (Canonical) | C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O |
SMILES (Isomeric) | C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O |
InChI | InChI=1S/C22H18O10/c23-11-6-14(25)12-8-19(32-22(30)10-4-16(27)20(29)17(28)5-10)21(31-18(12)7-11)9-1-2-13(24)15(26)3-9/h1-7,19,21,23-29H,8H2/t19-,21-/m1/s1 |
InChI Key | LSHVYAFMTMFKBA-TZIWHRDSSA-N |
Popularity | 956 references in papers |
Molecular Formula | C22H18O10 |
Molecular Weight | 442.40 g/mol |
Exact Mass | 442.08999677 g/mol |
Topological Polar Surface Area (TPSA) | 177.00 Ų |
XlogP | 1.50 |
Atomic LogP (AlogP) | 2.53 |
H-Bond Acceptor | 10 |
H-Bond Donor | 7 |
Rotatable Bonds | 3 |
1257-08-5 |
Epicatechin gallate |
(-)-Epicatechin-3-O-gallate |
(-)-epicatechingallate |
L-Epicatechin gallate |
epicatechin monogallate |
(-)-Epicatechin-3-gallate |
Teatannin |
(-)-Epicatechin 3-O-gallate |
ECG |
There are more than 10 synonyms. If you wish to see them all click here. |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.8422 | 84.22% |
Caco-2 | - | 0.9372 | 93.72% |
Blood Brain Barrier | - | 0.8000 | 80.00% |
Human oral bioavailability | - | 0.7286 | 72.86% |
Subcellular localzation | Mitochondria | 0.6166 | 61.66% |
OATP2B1 inhibitior | + | 0.7032 | 70.32% |
OATP1B1 inhibitior | + | 0.7038 | 70.38% |
OATP1B3 inhibitior | - | 0.5697 | 56.97% |
MATE1 inhibitior | - | 0.7400 | 74.00% |
OCT2 inhibitior | - | 0.8500 | 85.00% |
BSEP inhibitior | - | 0.4828 | 48.28% |
P-glycoprotein inhibitior | - | 0.5530 | 55.30% |
P-glycoprotein substrate | - | 0.8973 | 89.73% |
CYP3A4 substrate | + | 0.5954 | 59.54% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | - | 0.7217 | 72.17% |
CYP3A4 inhibition | - | 0.7662 | 76.62% |
CYP2C9 inhibition | - | 0.8369 | 83.69% |
CYP2C19 inhibition | - | 0.8089 | 80.89% |
CYP2D6 inhibition | - | 0.9553 | 95.53% |
CYP1A2 inhibition | - | 0.8058 | 80.58% |
CYP2C8 inhibition | + | 0.7473 | 74.73% |
CYP inhibitory promiscuity | - | 0.8067 | 80.67% |
UGT catelyzed | - | 0.5000 | 50.00% |
Carcinogenicity (binary) | - | 1.0000 | 100.00% |
Carcinogenicity (trinary) | Non-required | 0.6339 | 63.39% |
Eye corrosion | - | 0.9906 | 99.06% |
Eye irritation | + | 0.6035 | 60.35% |
Skin irritation | - | 0.6348 | 63.48% |
Skin corrosion | - | 0.9587 | 95.87% |
Ames mutagenesis | + | 0.5100 | 51.00% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.8554 | 85.54% |
Micronuclear | + | 0.8859 | 88.59% |
Hepatotoxicity | + | 0.6250 | 62.50% |
skin sensitisation | - | 0.8369 | 83.69% |
Respiratory toxicity | + | 0.6333 | 63.33% |
Reproductive toxicity | + | 0.8444 | 84.44% |
Mitochondrial toxicity | + | 0.6625 | 66.25% |
Nephrotoxicity | - | 0.7481 | 74.81% |
Acute Oral Toxicity (c) | IV | 0.3764 | 37.64% |
Estrogen receptor binding | + | 0.7558 | 75.58% |
Androgen receptor binding | + | 0.8604 | 86.04% |
Thyroid receptor binding | + | 0.6077 | 60.77% |
Glucocorticoid receptor binding | + | 0.6545 | 65.45% |
Aromatase binding | - | 0.8091 | 80.91% |
PPAR gamma | + | 0.6090 | 60.90% |
Honey bee toxicity | - | 0.8279 | 82.79% |
Biodegradation | - | 0.8250 | 82.50% |
Crustacea aquatic toxicity | + | 0.5750 | 57.50% |
Fish aquatic toxicity | + | 0.9197 | 91.97% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL3404 | P52209 | 6-phosphogluconate dehydrogenase |
210 nM |
IC50 |
PMID: 18313308
|
CHEMBL4860 | P10415 | Apoptosis regulator Bcl-2 |
229.09 nM 400 nM 230 nM 400 nM |
Ki Ki Ki Ki |
PMID: 18040043
DOI: 10.1007/s00044-009-9233-5 via Super-PRED via Super-PRED |
CHEMBL1293236 | P46063 | ATP-dependent DNA helicase Q1 |
707.9 nM |
Potency |
via Super-PRED
|
CHEMBL2362978 | P43351 | DNA repair protein RAD52 homolog |
255 nM |
IC50 |
via Super-PRED
|
CHEMBL4105924 | Q14576 | ELAV-like protein 3 |
200 nM |
IC50 |
via Super-PRED
|
CHEMBL3717 | P08581 | Hepatocyte growth factor receptor |
10000 nM |
IC50 |
PMID: 19839593
|
CHEMBL260 | Q16539 | MAP kinase p38 alpha |
1470 nM |
IC50 |
PMID: 21080642
|
CHEMBL4662 | P28074 | Proteasome Macropain subunit MB1 |
124 nM 194 nM |
IC50 IC50 |
via Super-PRED
via Super-PRED |
CHEMBL1697668 | Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 |
3801.89 nM |
IC50 |
PMID: 23571415
|
CHEMBL1743121 | Q9NPD5 | Solute carrier organic anion transporter family member 1B3 |
4466.84 nM |
IC50 |
PMID: 23571415
|
CHEMBL1075138 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 |
281.8 nM |
Potency |
via Super-PRED
|
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.49% | 91.11% |
CHEMBL1951 | P21397 | Monoamine oxidase A | 99.32% | 91.49% |
CHEMBL3194 | P02766 | Transthyretin | 96.50% | 90.71% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 92.67% | 96.09% |
CHEMBL3475 | P05121 | Plasminogen activator inhibitor-1 | 92.47% | 83.00% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 90.88% | 97.09% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 90.49% | 86.33% |
CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 | 88.53% | 96.37% |
CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 88.40% | 99.23% |
CHEMBL245 | P20309 | Muscarinic acetylcholine receptor M3 | 87.25% | 97.53% |
CHEMBL2535 | P11166 | Glucose transporter | 86.71% | 98.75% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 86.67% | 89.00% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 85.66% | 99.17% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 83.58% | 95.56% |
CHEMBL4208 | P20618 | Proteasome component C5 | 82.85% | 90.00% |
CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 82.82% | 99.15% |
CHEMBL2581 | P07339 | Cathepsin D | 82.77% | 98.95% |
CHEMBL340 | P08684 | Cytochrome P450 3A4 | 80.58% | 91.19% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
PubChem | 107905 |
NPASS | NPC160512 |
ChEMBL | CHEMBL36327 |
LOTUS | LTS0071606 |
wikiData | Q5382492 |